This difference was not observed when comparing the PSP-CBD group with the control group with high PIB-PET-SUVR, suggesting that low DYRK1A level is not a strong risk marker for PSP-CBD. The gene discussed is DYRK1A; the disease is supranuclear palsy, progressive, 1.